42307 Matching-adjusted indirect comparison of efficacy of ixekizumab versus secukinumab through 1 year in pediatric patients with severe plaque psoriasis
Saved in:
Published in | Journal of the American Academy of Dermatology Vol. 89; no. 3; p. AB193 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.09.2023
|
Online Access | Get full text |
Cover
Loading…
Author | Ardekani, Gholamreza S. Lansang, Perla See, Kyoungah Garrelts, Alyssa Jossart, Christian Prajapati, Vimal H. Swanson, Lisa Chao, Yan-Cheng |
---|---|
Author_xml | – sequence: 1 givenname: Vimal H. surname: Prajapati fullname: Prajapati, Vimal H. organization: Dermatology Research Institute, Calgary, AB, Canada; Skin Health & Wellness Centre, Calgary, AB, Canada; Probity Medical Research, Calgary, AB, Canada; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, AB, Canada – sequence: 2 givenname: Lisa surname: Swanson fullname: Swanson, Lisa organization: St Luke's Children's Hospital, Boise, ID, USA – sequence: 3 givenname: Christian surname: Jossart fullname: Jossart, Christian organization: Eli Lilly and Company, Indianapolis, IN, USA – sequence: 4 givenname: Kyoungah surname: See fullname: See, Kyoungah organization: Eli Lilly and Company, Indianapolis, IN, USA – sequence: 5 givenname: Alyssa surname: Garrelts fullname: Garrelts, Alyssa organization: Eli Lilly and Company, Indianapolis, IN, USA – sequence: 6 givenname: Gholamreza S. surname: Ardekani fullname: Ardekani, Gholamreza S. organization: Eli Lilly and Company, Indianapolis, IN, USA – sequence: 7 givenname: Yan-Cheng surname: Chao fullname: Chao, Yan-Cheng organization: Eli Lilly and Company, Indianapolis, IN, USA – sequence: 8 givenname: Perla surname: Lansang fullname: Lansang, Perla organization: Sunnybrook Health Sciences Centre, Toronto, ON, Canada |
BookMark | eNp9kE1OwzAQRi0EEqVwAVa-QILttHYssUGIPwnEhr3l2mM6aZsEOwHKUTgtLmXN6huN9D7NvBNy2HYtEHLOWckZlxdN2VjrS8FEVTJVKlUdkAlnWhVS1eqQTBjXrNBSiGNyklLDGNOzSk3I90xUTNEnO7gltq-F9c2YBvAUW48R3EBdt-ltxNS1tAsUQkBn3XY34yes8Gvc2AV9h5jGRBO4cYXt72pYxm58XVJOt2Bj7qM9eLRDREd7OyC0Q6IfOCwzlXGg_dq-jTlSF9EmTKfkKNh1grO_nJKX25uX6_vi8fnu4frqsXBaVsWcBxfswslKzZVinAlf85kEUFzW4IMALnUFCy1qrWohrRd6VodFZuYK5q6aErGvdbFLKUIwfcSNjVvDmdnJNY3ZyTU7uYYpk-Vm6HIPQT7sHSGa5PJHDvbSjO_wP_wHmtOIgg |
ContentType | Journal Article |
Copyright | 2023 |
Copyright_xml | – notice: 2023 |
DBID | AAYXX CITATION |
DOI | 10.1016/j.jaad.2023.07.773 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-6787 |
EndPage | AB193 |
ExternalDocumentID | 10_1016_j_jaad_2023_07_773 S0190962223021308 |
GroupedDBID | --- --K --M -RU .1- .FO .GJ .XZ .~1 0R~ 1B1 1CY 1P~ 1RT 1~. 1~5 354 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8F7 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AAWTL AAXUO ABBQC ABFNM ABFRF ABJNI ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFFNX AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 CAG COF CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEA HMK HMO HVGLF HX~ HZ~ IHE J1W J5H KOM LCYCR LZ2 M27 M41 MO0 N9A O-L O9- OAUVE OB. OBH OHH OM~ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SDF SDG SDP SEL SES SJN SPCBC SSH SSZ T5K TEORI UHS UNMZH UV1 WOW WUQ Y6R YFH Z5R ZCG ZGI ZY1 ~G- AAXKI AAYXX ADVLN AFJKZ AKRWK CITATION |
ID | FETCH-LOGICAL-c963-51fcfabc6375770102d8146ee7168edf2e1693eb92897826ad2948fbfab57e5c3 |
IEDL.DBID | AIKHN |
ISSN | 0190-9622 |
IngestDate | Thu Sep 26 18:49:14 EDT 2024 Fri Feb 23 02:35:46 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c963-51fcfabc6375770102d8146ee7168edf2e1693eb92897826ad2948fbfab57e5c3 |
ParticipantIDs | crossref_primary_10_1016_j_jaad_2023_07_773 elsevier_sciencedirect_doi_10_1016_j_jaad_2023_07_773 |
PublicationCentury | 2000 |
PublicationDate | September 2023 2023-09-00 |
PublicationDateYYYYMMDD | 2023-09-01 |
PublicationDate_xml | – month: 09 year: 2023 text: September 2023 |
PublicationDecade | 2020 |
PublicationTitle | Journal of the American Academy of Dermatology |
PublicationYear | 2023 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
SSID | ssj0009437 |
Score | 2.4674065 |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | AB193 |
Title | 42307 Matching-adjusted indirect comparison of efficacy of ixekizumab versus secukinumab through 1 year in pediatric patients with severe plaque psoriasis |
URI | https://dx.doi.org/10.1016/j.jaad.2023.07.773 |
Volume | 89 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1NS8MwNMwNxIv4ifNj5OBN6rY2bdrjGI6pbBcn7FaSNIVu2hW7gvPgD_HX-t6aTgXx4C1NeaHNe3lfeR-EXErPjkSHx5YvtWMxIXAklcUk6AbCjpnvYXLyaOwNH9nd1J3WSL_KhcGwSsP7S56-5tZmpm12s50lSfsBs6ADD-UbyCkHE34bII5sv04avdv74fir9i5zNlnTCGByZ8owr5kQWDDUdrCGJ-fO7_Lpm8wZ7JFdoyzSXvk9-6Sm0wOyPTLX4Yfkg2GANR0BO0VHkiWiWYHuS4oX0fhbVG3aDNJFTDXWixBqhePkVc-Tt-JZSIqRGUVOc62KeZKup0z7HtqlKzgKsB7Nqp4e1JRizSn6cAEKwDXNngRIGJrlC6DoPMmPyGRwM-kPLdNswVJwBi23G6tYSOU53OUcC81F6BzUGuwpX0exrbFqi5YBGGigVHgisgPmxxJgXK5d5RyTerpI9Qmh7tqKgjXgJWMRUIm2I7AbO0qD_iGCJrmqdjjMypIaYRVrNgsRHyHiI-zwEPDRJG6FhPAHYYTA8_-AO_0n3BnZwacyjOyc1Jcvhb4AvWMpW2Tr-r3bMtT1Ce6V2nw |
link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1NS8MwNIwN1Iv4ifMzB29StrVpux7HcGzu4-KE3UKSptBNu2JXcP4Uf63vrelUEA_eQsILbd7L-8r7IORWenYomn5ktaV2LCYEjqSymATdQNgRa3uYnDyeeP0n9jBzZxXSLXNhMKzS8P6Cp2-4tZlpmNNspHHceMQs6MBD-QZyysGE3xpoAwHczlpnMOxPvmrvMmebNY0AJnemCPOaC4EFQ20Ha3j6vvO7fPomc3oHZN8oi7RTfM8hqejkiOyMzXP4MflgGGBNx8BO0ZFkiXCeo_uS4kM0_hZV2zaDdBlRjfUihFrjOH7Ti_g9fxGSYmRGntFMq3wRJ5sp076HtugargLsR9Oypwc1pVgzij5cgAJwTdNnARKGptkSKDqLsxMy7d1Pu33LNFuwFNxBy21FKhJSeY7v-j4WmgvROag12FNtHUa2xqotWgZgoIFS4YnQDlg7kgDj-tpVzimpJstEnxHqbqwo2AMWGQuBSrQdgt3YVBr0DxHUyV15wjwtSmrwMtZszhEfHPHBmz4HfNSJWyKB_yAMDjz_D7jzf8LdkN3-dDzio8FkeEH2cKUIKbsk1dVrrq9AB1nJa0Njnzoi3HA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=42307+Matching-adjusted+indirect+comparison+of+efficacy+of+ixekizumab+versus+secukinumab+through+1+year+in+pediatric+patients+with+severe+plaque+psoriasis&rft.jtitle=Journal+of+the+American+Academy+of+Dermatology&rft.au=Prajapati%2C+Vimal+H.&rft.au=Swanson%2C+Lisa&rft.au=Jossart%2C+Christian&rft.au=See%2C+Kyoungah&rft.date=2023-09-01&rft.issn=0190-9622&rft.volume=89&rft.issue=3&rft.spage=AB193&rft_id=info:doi/10.1016%2Fj.jaad.2023.07.773&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jaad_2023_07_773 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0190-9622&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0190-9622&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0190-9622&client=summon |